top of page

What Will the Future Hold for ASX Cannabis Stocks: Exploring the Top 10 Companies in 2025

Updated: Nov 12, 2024

As the awareness of cannabis benefits grows, the Australian Stock Exchange (ASX) has become a hotspot for cannabis stocks. The sector is changing rapidly, enticing investors who recognize its potential. In this post, we will dive into the top 10 cannabis companies on the ASX as of 2025, highlighting their strategies and potential for success amidst an evolving industry landscape.


ASX Cannabis Overview
The rising trend of cannabis stocks on the ASX.

1. Cannabliss420


Leading the ASX cannabis scene is Cannabliss420, dedicated to high-quality cannabis products for medicinal and recreational use. They use sustainable farming methods and cutting-edge extraction techniques to ensure purity and potency.


With a distribution network that spans the country, Cannabliss420 aims for a significant market share. Their collaborations with healthcare providers enhance their credibility and reach, setting them apart in a crowded field. In 2025, they expect to capture about 20% of the market share for recreational cannabis in Australia.


2. Australian Primary Hemp


Australian Primary Hemp stands out in the hemp industry by emphasizing sustainability and organic development. Their product range includes seeds, oils, and fibers, catering to diverse consumer needs.


The company intends to broaden its offerings by 30% by 2025, focusing on health-oriented products that tap into the rising popularity of plant-based diets. This dedication to eco-friendly practices resonates with consumers, strengthening their brand loyalty.


3. Elixinol Global


In the ASX cannabis landscape, Elixinol Global excels in hemp-derived cannabidiol (CBD) products. Renowned for its commitment to quality, the company offers a range of items, such as oils, capsules, and topical applications.


To meet the surging demand for natural wellness solutions, Elixinol plans to increase its product line by 25% in the next two years. Their strong online presence fosters customer engagement, propelling their growth trajectory in this fast-paced environment.


4. THC Global Group


THC Global Group is revolutionizing Australia's medical cannabis landscape; their focus on research and development, combined with high-quality standards, positions them favorably.


By 2025, THC Global aims to double its cultivation capacity as they adapt to the increasing demands of healthcare professionals. This expansion will help them provide enhanced options for patients and healthcare providers alike.


5. Creso Pharma


Creso Pharma develops and markets cannabis-based pharmaceuticals and nutraceuticals. They create specific formulations designed for various health conditions, giving them a competitive edge.


Through collaborations with healthcare partners and leveraging clinical research, Creso Pharma plans to increase its market reach by 40% over the next two years. Their focus on specialized products meets the growing needs of the Australian healthcare system.


6. Medlab Clinical


Medlab Clinical is at the forefront of crafting innovative medicines using cannabis extracts. They focus on therapeutic products aimed at chronic pain management and other serious medical conditions.


As perceptions of cannabis shift, Medlab is in a prime position to deliver effective medical solutions. They expect their sales to rise by 50% by 2025, aligning their growth with evolving patient and healthcare provider needs.


7. Little Green Pharma


Little Green Pharma is dedicated to producing high-quality medicinal cannabis. Using organic farming methods, they prioritize sustainability in cultivation.


Looking ahead, Little Green Pharma plans to expand into international markets. By 2025, they expect to derive nearly 30% of their revenue from exports as cannabis regulations worldwide continue to evolve.


8. Asterion Cannabis


Asterion Cannabis is a newcomer focusing on innovative cultivation and production methods. Their commitment to research positions them well within the cannabis science sector.


By building strong ties with regulators and healthcare professionals, Asterion aims to enhance acceptance and growth in the market. They anticipate a market entry in 2025 with a potential revenue of over $10 million in their first year.


9. Zenabis Global


Zenabis Global utilizes its advanced production capabilities to offer a wide array of cannabis products. Their significant investments in high-tech facilities prepare them to meet both domestic and international market needs.


With a goal to increase their online retail presence, Zenabis projects a 35% growth in market share by 2025, positioning themselves favorably in a competitive landscape.


10. Harvest One Cannabis


Harvest One Cannabis operates across multiple cannabis sectors, including health products and oils. Their diverse portfolio enables them to reach a broad audience and quickly adapt to trends.


By setting their sights on strategic acquisitions, Harvest One aims to boost growth within the ASX cannabis framework. They are targeting a 25% increase in their market presence by 2025 through these initiatives.


Looking Ahead


The future for ASX cannabis stocks looks bright, with companies eager to adapt and thrive in this growing industry. Each of the ten companies described has carved its niche, ready to seize upcoming trends and meet consumer needs.


As public attitudes shift and regulations become more supportive, stronger growth in the cannabis sector is likely. For potential investors, observing these leading companies as they navigate this dynamic landscape is crucial.


As the market matures, staying informed will help you understand how these businesses adapt to future challenges and opportunities in the cannabis industry.


Cannabis Industry Growth
The rise of cannabis stocks in Australia showcasing growth opportunities.

Ultimately, as the ASX cannabis market progresses, these companies will play a key role in shaping its trajectory. Whether you are an investor or a cannabis enthusiast, the next few years promise exciting developments for all involved.

bottom of page